Influence of immunoglobulin G-glycan and subclass variation on antibody effector functions

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Chemistry

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Adaptive antibody diversification through N-linked glycosylation of the immunoglobulin variable region

  2018cited by this paper
• IgG4-Related Disease

  2018cited by this paper
• Humanized Mouse Models of Clinical Disease.

  2017cited by this paper
• Antenatal management in fetal and neonatal alloimmune thrombocytopenia: a systematic review.

  2017cited by this paper
• Identification of Fc Gamma Receptor Glycoforms That Produce Differential Binding Kinetics for Rituximab*

  2017cited by this paper
• IgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severity

  2017cited by this paper
• Rheumatoid factors do not preferentially bind to ACPA-IgG or IgG with altered galactosylation.

  2017cited by this paper
• Antigen specificity determines anti‐red blood cell IgG‐Fc alloantibody glycosylation and thereby severity of haemolytic disease of the fetus and newborn

  2017cited by this paper
• RhIg-prophylaxis is not influenced by FCGR2/3 polymorphisms involved in red blood cell clearance.

  2017cited by this paper
• Enhanced Effector Functions Due to Antibody Defucosylation Depend on the Effector Cell Fcγ Receptor Profile

  2017cited by this paper
• Sensitivity of Fetal RhD Screening for Safe Guidance of Targeted Anti-D Immunoglobulin Prophylaxis: Prospective Cohort Study of a Nationwide Programme in the Netherlands

  2017cited by this paper
• The N-Glycosylation of Mouse Immunoglobulin G (IgG)-Fragment Crystallizable Differs Between IgG Subclasses and Strains

  2017cited by this paper
• Affinity of human IgG subclasses to mouse Fc gamma receptors

  2017cited by this paper
• Identification of sequence variants influencing immunoglobulin levels

  2017cited by this paper
• Sialyltransferase and Neuraminidase Levels/Ratios and Sialic Acid Levels in Peripheral Blood B Cells Correlate with Measures of Disease Activity in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: A Pilot Study

  2016cited by this paper
• The Emerging Importance of IgG Fab Glycosylation in Immunity

  2016cited by this paper
• The immunoglobulin G1 N-glycan composition affects binding to each low affinity Fc γ receptor

  2016cited by this paper
• Antibody Production in Plants and Green Algae.

  2016cited by this paper
• Interpolation method for accurate affinity ranking of arrayed ligand-analyte interactions.

  2016cited by this paper
• Structural Analysis of Variable Domain Glycosylation of Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis Reveals the Presence of Highly Sialylated Glycans*

  2016cited by this paper
• Murine Plasma N-Glycosylation Traits Associated with Sex and Strain.

  2016cited by this paper
• Isotype‐specific glycosylation analysis of mouse IgG by LC‐MS

  2016cited by this paper
• Fc gamma receptors: glycobiology and therapeutic prospects

  2016cited by this paper
• Analysis of allergic immune responses in humanized mice.

  2016cited by this paper
• Antibodies to watch in 2016

  2016cited by this paper
• Humanized Mouse Xenograft Models: Narrowing the Tumor-Microenvironment Gap.

  2016cited by this paper
• Serological blind spots for variants of human IgG3 and IgG4 by a commonly used anti‐immunoglobulin reagent

  2016cited by this paper
• B-cell–independent sialylation of IgG

  2016cited by this paper
• The Production Processes and Biological Effects of Intravenous Immunoglobulin

  2016cited by this paper
• Characterizing the effect of multiple Fc glycan attributes on the effector functions and FcγRIIIa receptor binding activity of an IgG1 antibody

  2016cited by this paper
• Immune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodies

  2016cited by this paper
• Antigen-Specific Antibody Glycosylation Is Regulated via Vaccination

  2016cited by this paper
• Impact of Fc gamma-receptor polymorphisms on the response to rituximab treatment in children and adolescents with mature B cell lymphoma/leukemia

  2016cited by this paper
• Antibodies to watch in 2017

  2016cited by this paper
• Glycosylation pattern of anti‐platelet IgG is stable during pregnancy and predicts clinical outcome in alloimmune thrombocytopenia

  2016cited by this paper
• A Novel Platform for the Potentiation of Therapeutic Antibodies Based on Antigen-Dependent Formation of IgG Hexamers at the Cell Surface

  2016cited by this paper
• N-Glycosylation Design and Control of Therapeutic Monoclonal Antibodies.

  2016cited by this paper
• Multi-level glyco-engineering techniques to generate IgG with defined Fc-glycans

  2016cited by this paper
• Comparison of Fc N-Glycosylation of Pharmaceutical Products of Intravenous Immunoglobulin G

  2015cited by this paper
• The Structural Role of Antibody N-Glycosylation in Receptor Interactions.

  2015cited by this paper
• Complement System Part I – Molecular Mechanisms of Activation and Regulation

  2015cited by this paper
• Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity.

  2015cited by this paper
• Mouse and human FcR effector functions

  2015cited by this paper
• Glycans in the immune system and The Altered Glycan Theory of Autoimmunity: a critical review.

  2015cited by this paper
• Processing of complex N-glycans in IgG Fc-region is affected by core fucosylation

  2015cited by this paper
• Extensive glycosylation of ACPA-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritis

  2015cited by this paper
• Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid

  2015cited by this paper
• Building better monoclonal antibody-based therapeutics

  2015cited by this paper
• A Monosaccharide Residue Is Sufficient to Maintain Mouse and Human IgG Subclass Activity and Directs IgG Effector Functions to Cellular Fc Receptors.

  2015cited by this paper
• A common glycan structure on immunoglobulin G for enhancement of effector functions

  2015cited by this paper
• Association of Systemic Lupus Erythematosus With Decreased Immunosuppressive Potential of the IgG Glycome

  2015cited by this paper
• Production of α2,6-sialylated IgG1 in CHO cells

  2015cited by this paper
• Engineered CHO cells for production of diverse, homogeneous glycoproteins

  2015cited by this paper
• In Vitro Glycoengineering of IgG1 and Its Effect on Fc Receptor Binding and ADCC Activity

  2015cited by this paper
• Prophylactic anti‐D preparations display variable decreases in Fc‐fucosylation of anti‐D

  2015cited by this paper
• C-reactive protein enhances IgG-mediated phagocyte responses and thrombocytopenia.

  2015cited by this paper
• Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants

  2015cited by this paper
• Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity

  2015cited by this paper
• Differences in Anti-Inflammatory Actions of Intravenous Immunoglobulin between Mice and Men: More than Meets the Eye

  2015cited by this paper
• Hinge-Region O-Glycosylation of Human Immunoglobulin G3 (IgG3)

  2015cited by this paper
• Inflammatory Bowel Disease Associates with Proinflammatory Potential of the Immunoglobulin G Glycome

  2015cited by this paper
• The therapeutic monoclonal antibody market

  2015cited by this paper
• The Serum Immunoglobulin G Glycosylation Signature of Gastric Cancer.

  2015cited by this paper
• The neonatal Fc receptor (FcRn) binds independently to both sites of the IgG homodimer with identical affinity

  2015cited by this paper
• Structural analysis of Fc/FcγR complexes: a blueprint for antibody design

  2015cited by this paper
• Glycomic Signatures on Serum IgGs for Prediction of Postvaccination Response

  2015cited by this paper
• Dynamics of Inter-heavy Chain Interactions in Human Immunoglobulin G (IgG) Subclasses Studied by Kinetic Fab Arm Exchange

  2014cited by this paper
• GlycoDelete engineering of mammalian cells simplifies N-glycosylation of recombinant proteins

  2014cited by this paper
• Antibody- and TRIM21-dependent intracellular restriction of Salmonella enterica.

  2014cited by this paper
• Inhibition of FcγR-mediated phagocytosis by IVIg is independent of IgG-Fc sialylation and FcγRIIb in human macrophages.

  2014cited by this paper
• Highly parallel characterization of IgG Fc binding interactions

  2014cited by this paper
• Humanized FcRn mouse models for evaluating pharmacokinetics of human IgG antibodies.

  2014cited by this paper
• The function of Fcγ receptors in dendritic cells and macrophages

  2014cited by this paper
• IgG-effector functions: "the good, the bad and the ugly".

  2014cited by this paper
• Molecular Evolution of Broadly Neutralizing Llama Antibodies to the CD4-Binding Site of HIV-1

  2014cited by this paper
• The Complement System

  2014cited by this paper
• Bridging autoantibodies and arthritis: the role of Fc receptors.

  2014cited by this paper
• Dendritic cell immunoreceptor: a novel receptor for intravenous immunoglobulin mediates induction of regulatory T cells.

  2014cited by this paper
• Complement Is Activated by IgG Hexamers Assembled at the Cell Surface

  2014cited by this paper
• Identification of Distinct Glycoforms of IgA1 in Plasma from Patients with Immunoglobulin A (IgA) Nephropathy and Healthy Individuals*

  2014cited by this paper
• IgG Subclasses and Allotypes: From Structure to Effector Functions

  2014cited by this paper
• Characterization and screening of IgG binding to the neonatal Fc receptor

  2014cited by this paper
• Therapeutic Effect of IVIG on Inflammatory Arthritis in Mice Is Dependent on the Fc Portion and Independent of Sialylation or Basophils

  2014cited by this paper
• Boosting ADCC and CDC activity by Fc engineering and evaluation of antibody effector functions.

  2014cited by this paper
• Fc gamma receptor glycosylation modulates the binding of IgG glycoforms: a requirement for stable antibody interactions.

  2014cited by this paper
• A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy.

  2014cited by this paper
• The Majority of Human Memory B Cells Recognizing RhD and Tetanus Resides in IgM+ B Cells

  2014cited by this paper
• H435‐containing immunoglobulin G3 allotypes are transported efficiently across the human placenta: implications for alloantibody‐mediated diseases of the newborn

  2014cited by this paper
• Low anti-RhD IgG-Fc-fucosylation in pregnancy: a new variable predicting severity in haemolytic disease of the fetus and newborn

  2014cited by this paper
• Platelets Support Extracellular Sialylation by Supplying the Sugar Donor Substrate*♦

  2014cited by this paper
• Total plasma N-glycome changes during pregnancy.

  2014cited by this paper
• Immunoglobulin G (IgG) Fab Glycosylation Analysis Using a New Mass Spectrometric High-throughput Profiling Method Reveals Pregnancy-associated Changes*

  2014cited by this paper
• Restricted motion of the conserved immunoglobulin G1 N-glycan is essential for efficient FcγRIIIa binding.

  2014cited by this paper
• Structural characterization of anti-inflammatory immunoglobulin G Fc proteins.

  2014cited by this paper
• Haplotypes of FcγRIIa and FcγRIIIb Polymorphic Variants Influence IgG-Mediated Responses in Neutrophils

  2014cited by this paper
• Broad requirement for terminal sialic acid residues and FcγRIIB for the preventive and therapeutic activity of intravenous immunoglobulins in vivo

  2014cited by this paper
• Sialylation may be dispensable for reciprocal modulation of helper T cells by intravenous immunoglobulin

  2014cited by this paper
• A simple, robust and highly efficient transient expression system for producing antibodies.

  2014cited by this paper
• Quantitative mapping of glycoprotein micro-heterogeneity and macro-heterogeneity: an evaluation of mass spectrometry signal strengths using synthetic peptides and glycopeptides.

  2013cited by this paper
• Development of orally active inhibitors of protein and cellular fucosylation

  2013cited by this paper

• Variability of serum IgG sialylation and galactosylation degree in women with advanced endometriosis

  2021cites this paper